Gelled composition
A gelled composition with dead/inactivated Lactobacillaceae cells addresses taste and texture issues of existing powders, enhancing consumer compliance and efficacy by providing a pleasant chewy format for easy and complete dosing.
Patent Information
- Application Number
- PCT/EP2026/063454
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2026-03-03
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-12
AI Technical Summary
Existing digestive postbiotic powders from the Lactobacillaceae family face challenges such as unpleasant taste, texture issues, and difficulty in consumption, leading to incomplete dosing and potential interaction with food or drinks, which affects efficacy.
A gelled composition is developed using dead/inactivated cells from the Lactobacillaceae family, combined with a gelling agent, sweetener, edible acid, and optional flavoring, which is formed into a chewy gel format to improve palatability and ease of consumption.
The gelled composition provides a pleasant taste and texture, facilitating complete dosing and maintaining efficacy by ensuring the active ingredients are fully consumed, while being suitable for commercialization with a stable shelf-life.
Smart Images

Figure IMGF000021_0001_TABLE 
Figure IMGF000021_0002_TABLE 
Figure IMGF000022_0001_TABLE
Abstract
Description
[0001] 2025P00124WO (34829- WO- PCT)
[0002] 1
[0003] GELLED COMPOSITION
[0004] FIELD OF THE INVENTION
[0005] The invention relates to a novel gelled composition comprising inanimate cells from the Lactobacillaceae family and their fermentation components that confer a health benefit.
[0006] BACKGROUND OF THE INVENTION
[0007] Non-viable microorganisms or fragments thereof and / or microbial cell extracts, mainly heat-killed (including tyndallized) bacteria (e.g. lactic acid bacteria), are able to produce beneficial effects. For example, dead cells of lactic acid bacteria are useful to produce a psychobiotic effect in a human (WO 2019 / 180263), in stimulating the growth of bifidobacteria in the human gut (WO 2021 / 219846) or to treat or prevent an allergic disease (EP-A-2796142).
[0008] The digestive postbiotic powders Lacteol® and Humiome® Post LB, commercially available at dsm-firmenich, both contain heat-treated (inanimate) Lactobacillus LB (combination of Limosilactobacillus fermentum (CNCM I-2998) and Lactobacillus delbrueckii (CNCM 1-4831)) and dried culture medium fermentation including peptides, amino acids, carbohydrates, carbon and minerals. They are used to manage digestive disorders including diarrhoea, restore gut health and improve digestive comfort.
[0009] Powders may be administered in several ways. By direct oral administration the consumer or patient directly consumes the powder by placing it on the tongue and swallowing it with or without water. However, consumers / patients may find the powder having an unpleasant taste which can make it difficult to consume, or the powdery texture can be so uncomfortable that it may cause gagging or coughing. Alternatively, powders can be mixed with a small amount of food (e.g., applesauce, yogurt) or drink (e.g., water, juice) to mask the taste and make it easier to swallow; the powder may alter the taste of the food or drink, though, making it unpalatable. There may be a risk that the patient / consumer may not consume the entire dose if some powder remains in the container or if the food / drink is not fully consumed. In addition, some powders may not dissolve well or may react with certain foods or drinks, affecting the efficacy of the active ingredient. Another way of oral administration of powders may be in unit dosage form where the powder is pre-measured and packaged in e.g. capsules or sachets, which can be swallowed directly or mixed with water before consumption; however, opening sachets and mixing the powder can be inconvenient and time-consuming or patients / consumer with dysphagia or difficulty swallowing may struggle to consume capsules.2025P00124WO (34829- WO- PCT)
[0010] 2
[0011] There is a need for providing an alternative formulation of digestive postbiotic powders that overcomes one or more of the above disadvantages and has proper shelf-life making it suitable to commercialize.
[0012] SUMMARY OF THE INVENTION
[0013] The first aspect of the inventions relates to a gelled composition for oral administration comprising a composition containing dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, preferably in 2-8 wt% based on the total weight of the gelled composition. The second aspect of the present application relates to a method for producing the gelled composition as defined in the first aspect of the invention, the method comprising the steps of:
[0014] a) mixing and heating a gelling agent, a first portion of a sweetener, preferably in powder form, and an edible acid, preferably its nutritionally acceptable salt, in water, b) adding a warm syrup of a second portion of a sweetener to the solution obtained in step a) and heating further,
[0015] c) adding an aqueous solution of a powder of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein to the solution obtained in step b), optionally with an emulsifier, and heating further to obtain a liquid gummy mass, d) optionally, adding a flavouring and / or a colorant, to the gummy mass obtained in step c) and distribute evenly,
[0016] e) addition of an edible acid,
[0017] f) depositing the warm liquid gummy mass obtained in step e) into moulds and allowing to cool and dry, and optionally
[0018] g) coating the so-obtained gelled composition with glazing and / or sanding agent.
[0019] The third aspect of the invention relates to a gelled composition for oral administration comprising dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, obtained or obtainable by the method comprising the steps:
[0020] i) heating an aqueous solution of comprising a gelling agent, a first portion of a sweetener and an edible acid, preferably a nutritionally acceptable salt of an edible acid, in water at 60-80 °C until the gelling agent is hydrated,2025P00124WO (34829- WO- PCT)
[0021] 3
[0022] ii) adding a warm syrup or solution of a second portion of the sweetener to the solution obtained in step i) and brought to boiling until a solution or syrup of 75-80 Bx° is obtained,
[0023] iii) adding a 25-75 wt% aqueous solution of a powder of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein and optionally an emulsifier to the solution obtained in step ii),
[0024] iv) continuing boiling the solution obtained in step iii) until a solution or syrup of 75-80 Bx° is obtained,
[0025] v) optionally, adding a flavouring and / or a colorant to the solution obtained in step iv) and distributing evenly,
[0026] vi) adding an edible acid to set the pH of the solution obtained in step iv) or v) to 2.8-3.8, vii) depositing the warm liquid gummy mass obtained in step vi) into moulds and allowing to cool and dry, and optionally
[0027] viii) coating the so-obtained gelled composition with glazing and / or sanding agent.
[0028] The fourth aspect of the invention relates to a non-medical use of the gelled composition as defined in the first or the third aspect of the invention.
[0029] DETAILED DESCRIPTION OF THE INVENTION
[0030] Herein, the following terms have the following meanings:
[0031] “About” or “around” means + / - 5 %.
[0032] “Billion” is one thousand million, that is 109(ten to the ninth power).
[0033] “Brix” refers to degrees Brix, which corresponds to the total dissolved solid (TDS) content of an aqueous solution (g of dissolved solid in 100 g of solution). The rest is water. Brix is measured by a calibrated refractometer at room temperature.
[0034] “Free from lactose” in the context of the present application means that no lactose is used during the production process, either in fermentation or in the drying step, and accordingly no lactose can be detected either in the fermentation broth or in the concentrated broth before or after heat treatment, or in the dried product (powder composition) as disclosed (limit of detection: 50 mg / kg).
[0035] “Gelled composition” in the context of the present invention means a delivery system of a drug or a nutritionally useful ingredient (active ingredient) designed in a self-supporting, chewy gel form (gum, gummy composition). The gelled composition is typically composed of gelatine,2025P00124WO (34829- WO- PCT)
[0036] 4
[0037] pectin, starch or agar that encapsulates the active ingredients, which are slowly released upon chewing as gel matrix begins to break down in the mouth. Gelled (or gummy) compositions can have a variety of forms, such as gelled bears, gelled worms, etc. Also, the sizes of the gelled composition can vary. The usual form of a gelled composition is a gelled confection. Such gelled compositions and confections are popular among consumers because they have an elastic texture and they can be relatively easily flavoured with a texture-matching flavour. At consumers who experience difficult swallowing, the chewable format of a gel formulation is favourable. Gelled compositions are especially preferred by children over tablets or capsules.
[0038] “Inactivated cells from the Lactobacillaceae family” preferably means inanimate Lactobacillaceae cells that have been made deliberately lifeless (dead or killed), therefore are not able to colonize under appropriate conditions, for example in the host’s gut. The degree of inactivation is at least 98 %, preferably at least 99 %, more preferably at least 99.5 %, even more preferably substantially all the cells of the microorganism are dead or killed, advantageously the entire population of the microorganism is dead or killed.
[0039] “Maltodextrin” is an oligosaccharide consisting of 3-20 D-glucose units that are connected to each other mostly by a(1^4) glycosidic bonds (but can have some a(1^6) branches). It is made by partial hydrolysis from corn, rice, potato starch or wheat.
[0040] “Non-therapeutical use” or “non-medical use” means - as opposed to the purpose of therapy which is to restore the organism from a pathological to its original condition, or to prevent pathology in the first place - an improvement of performance of the organism in a normal state. Therefore, the purpose of the non-therapeutical use is to enhance performance and perception of well-being in a healthy state of a mammal / individual or at least in a mammal / individual that is not likely to develop a pathological state.
[0041] “Nutraceutical composition” refers to a formulation that combines nutrients and / or bioactive compounds, designed to provide health benefits beyond basic nutrition. These compositions can be in the form of dietary supplements, functional foods, or beverages that aim to improve overall well-being.
[0042] “Substantially free” means less than 1 wt%.
[0043] The present inventors surprisingly found that postbiotic powder preparations, for example preparation of inanimate cells from the Lactobacillaceae family with their dried fermentation broth is suitable for making gelled compositions.
[0044] Therefore, the first aspect of the inventions relates to a gelled composition for oral administration comprising a composition containing dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived2025P00124WO (34829- WO- PCT)
[0045] 5
[0046] and the medium components therein, preferably in 2-8 wt% based on the total weight of the gelled composition. In this regard, the present invention is considered to be a gelled composition for oral administration comprising a postbiotic derived from a lactic acid bacteria. Preferably, the dead / inactivated Lactobacillaceae cells belong to the genus Limosilactobacillus, for example Lm. fermentum or Lm. reuteri, and / or to the genus Lactobacillus, for example L. acidophilus, L. delbrueckii, L. delbrueckii subsp. bulgaricus or L. johnsonii, and / or the genus Lactiplantibacillus, for example L. plantarum, and / or to the genus Lacticaseibacillus, for example L. rhamnosus or L. casei, and / or to the genus Levilactobacillus, for example L. brevis.
[0047] In one embodiment, the strain in the Lactobacillaceae family is not considered to be a probiotic. In a further preferred embodiment, the Limosilactobacillus is Limosilactobacillus fermentum as deposited at the Collection Nationale de Cultures de Microorganismes (CNCM) with the reference code I-2998. In other preferred embodiment, the Lactobacillus is Lactobacillus delbrueckii as deposited at the Collection Nationale de Cultures de Microorganismes (CNCM) with the reference code 1-4831.
[0048] In a particularly preferred embodiment, the Lactobacillaceae cells comprise or consist of two independent species: Limosilactobacillus fermentum and Lactobacillus delbrueckii, more preferably the strains of in the Limosilactobacillus fermentum and Lactobacillus delbrueckii species are not considered to be probiotics. The ratio of Limosilactobacillus fermentum to Lactobacillus delbrueckii by weight or cell count may be any suitable ratio from about 999:1 to about 9:1, e.g. about 99:1 to 9:1, including 50:1, 25:1, 19:1, particularly about 9:1-50:1, more preferably about 19:1. In an advantageous embodiment, the strain in Lactobacillaceae family is Lactobacillus LB consisting of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, preferably in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count). The Lactobacillus LB may conveniently be isolated from human faeces.
[0049] Lactobacillus LB in fermented culture medium (together with components of the culture medium fermentation including peptides, amino acids carbohydrates carbon and minerals) is deposited at the Collection Nationale de Cultures de Microorganismes (CNCM) with the reference code MA 65 / 4E.
[0050] In the context of the first aspect of the invention, the composition containing the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which it is derived and the medium components therein, including the preferred and further preferred embodiments disclosed above, is prepared by concentration of the fermentation broth of said microorganism followed by inactivation and drying the inactivated / dead cells together with the fermented culture medium to a powder (that is removing water from the medium). As a result, the preparation of the inactivated cells contains substances other than the intact cells, for2025P00124WO (34829- WO- PCT)
[0051] 6
[0052] example cell components (pili, cell wall components, etc.), fermentation additives like carbon and / or energy source used in the fermentation, microbial metabolites and / or end products like amino acids, peptides. The drying method comprises spray-drying, lyophilization, fluid bed drying or other appropriate process. In a particular embodiment, a carbohydrate compound, e.g. lactose, maltodextrin or cellobiose, may be added to the concentrated fermentation medium prior to drying. In another aspect, a carbohydrate compound, e.g. lactose, maltodextrin or cellobiose, may be added in the course of drying as part of the formulation step to make a dried powder of the dead / inactivated cells with or in the dried fermentation medium from which they are derived and the medium components therein. Preferably, the drying method is fluid bed drying.
[0053] In a preferred realization, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein comprises lactose, preferably in 50-85 wt% based on the total weight of the powder, more preferably in 65-85 wt%, even more preferably in 70-80 wt% or 75-82 wt%, and wherein further preferably the Lactobacillaceae cells comprise or consist of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, preferably in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count). This powder composition comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram. In a preferred realization, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein comprises lactose, preferably in 15-23 wt% based on the total weight of the powder, and comprises maltodextrin, the maltodextrin being preferably maltodextrin of 8-20 DE, more preferably 12-20 DE, preferably wherein the lactose and maltodextrin together are present in 50-85 wt% based on the total weight of the powder, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%, and wherein further preferably the Lactobacillaceae cells comprise or consist of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, preferably in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count). This powder composition comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram.
[0054] In a preferred realization, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein comprises lactose, preferably in 15-23 wt% based on the total weight of the powder, and comprises cellobiose, preferably wherein the lactose and cellobiose together are present in 50-85 wt% based on the total weight of the powder, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%, and wherein further preferably the Lactobacillaceae cells comprise or consist of Limosilactobacillus fermentum2025P00124WO (34829- WO- PCT)
[0055] 7
[0056] CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, preferably in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count). This powder composition comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram.
[0057] In a preferred realization, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein comprises lactose, preferably in 15-23 wt% based on the total weight of the powder, and comprises cellobiose and maltodextrin, the maltodextrin being preferably maltodextrin of 8-20 DE, more preferably 12-20 DE, preferably the lactose, cellobiose and maltodextrin together being present in 50-85 wt% based on the total weight of the powder, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%, and wherein further preferably the Lactobacillaceae cells comprise or consist of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, preferably in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count). This powder composition comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram.
[0058] In another preferred realization, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein is substantially free from lactose, preferably free from lactose, comprises maltodextrin, the maltodextrin being preferably maltodextrin of 8-20 DE, more preferably 12-20 DE, more preferably the maltodextrin being present in 65-85 wt% based on the total weight of the powder, even more preferably 70-80 wt% or 75-82 wt%, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously, and wherein further preferably the Lactobacillaceae cells comprise or consist of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, preferably in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count). This powder composition comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram.
[0059] In another preferred realization, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein is substantially free from lactose, preferably free from lactose, comprises cellobiose in 65-87 wt% based on the total weight of the powder, preferably in 75-85 wt%, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously, and further preferably wherein the Lactobacillaceae cells comprise or consist of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, preferably in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count). This powder composition comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram.2025P00124WO (34829- WO- PCT)
[0060] 8
[0061] In another preferred realization, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein is substantially free from lactose, preferably free from lactose, comprises cellobiose and maltodextrin, the maltodextrin being preferably maltodextrin of 8-20 DE, more preferably 12-20 DE, the cellobiose and maltodextrin being present preferably in 65-85 wt% based on the total weight of the powder, even more preferably 70-80 wt% or 75-82 wt%, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously, and wherein further preferably the Lactobacillaceae cells comprise or consist of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, preferably in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count). This powder composition comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram.
[0062] The gelled composition according to the first aspect of the invention, including the preferred and further preferred embodiments disclosed above, is preferably characterized in that it comprises at least one gelling substance (with other words: gelling agent). The gelling substance is an essential component in the gelled composition as it provides the chewy texture and forms the matrix that holds the other ingredients together. Preferably, the at least one gelling substance is selected from the group consisting of gelatine, pectin, starch, agar and other hydrocolloids, more preferably the gelling substance is gelatine and / or pectin. Also preferably, the gelling substance makes up 0.5-20 wt%, preferably 0.75-10 wt% of the gelled composition. More preferably, the gelling substance is pectin and present in 1-5 wt%.
[0063] Furthermore, the gelled composition according to the first aspect of the invention, including the preferred and further preferred embodiments disclosed above, is characterized in that it comprises a sweetener. Sweeteners enhance the taste of the gelled composition, make it palatable and contribute to the overall texture and consistency. The sweetener, preferably, makes up 40-80 wt%, preferably 60-75 wt% of the gelled composition. The sweetener, in one group of embodiments, is a usual sugar typically used for gelled confections to make them sweet, such as sucrose, glucose, fructose, maltose, maltooligosaccharides or any mixture thereof. In addition, these sugars make the gelled composition higher in calories. In other group of embodiments, particularly for consumption by diabetics or those who wish to control calorie intake, the sweetener is a low-calorie sugar alcohol, such as xylitol, erythritol, sorbitol, mannitol, isomalt, maltitol or any mixture thereof. As the low-calorie sugar alcohols are far less sweet than the digestible sugars above, they can be optionally mixed with artificial sweeteners such as aspartame, sucralose, stevia, saccharin, acesulfame K, neotame, advantame or cyclamate, to improve palatability, preferably up to 1:100 weight ratio in relation to the low-calorie sugar2025P00124WO (34829- WO- PCT)
[0064] 9
[0065] alcohol. In other group of embodiments, the sweetener comprises mix of usual sugar and low-calorie sugar alcohol.
[0066] In addition, the gelled composition according to the first aspect of the invention, including the preferred and further preferred embodiments disclosed above, is further characterized in that it comprises an edible acid. The acid provides a tangy taste and balances the sweetness, enhances the sensory experience, triggers salivation and also helps preserve the gummy bear by lowering the pH, which inhibits microbial growth. The edible acid can be an inorganic acid, for example phosphoric acid, and / or an organic acid, for example ascorbic acid, malic acid, citric acid, tartaric acid, fumaric acid, acetic acid or lactic acid, but especially citric acid or ascorbic acid is used for making the gelled composition claimed. In the present context, the term “edible acid” also covers the nutritionally acceptable salts of said acid, or the mixture of said acid and its nutritionally acceptable salt. The edible acid is usually present in 0.5-2 wt% in the gelled composition.
[0067] The gelled composition according to the first aspect of the invention, including the preferred and further preferred embodiments disclosed above is also characterized in that it contains water (moisture), preferably in 15-30 wt%, more preferably around 19-23 wt%.
[0068] Preferably, the gelled composition of the present invention is substantially free from lactose, more preferably free from lactose. In this case the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein used for making the gelled composition shall be substantially free from lactose, preferably free from lactose, as disclosed above. These gelled composition embodiments offer the benefits of the presently commercialized lactose containing postbiotic powders for those who cannot or don’t consume lactose due to dietary choices or health-related reasons. Furthermore, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, which is substantially free from lactose, preferably free from lactose, and used for making the gelled composition of the present invention, contains higher amounts of useful fermentation metabolites at the same or similar cell count compared to the commercial lactose-containing Humiome® Post LB powder. Therefore, increase of these metabolites in the lactose-free postbiotic powder and thereby in the gelled composition according to the present invention comprising the lactose-free postbiotic powder is deemed positive and beneficial.
[0069] Accordingly, a preferred embodiment of the first aspect is a gelled composition for oral administration comprising:2025P00124WO (34829- WO- PCT)
[0070] 10
[0071] a composition containing dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, as component A,
[0072] a gelling substance comprising gelatine, pectin, starch, agar and / or a hydrocolloid, preferably gelatine and / or pectin, more preferably pectin,
[0073] a sweetener,
[0074] an edible acid, and
[0075] - water,
[0076] wherein, preferably, component A comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram and is present in 2-8 wt% based on the total weight of the gelled composition, and more preferably the Lactobacillaceae cells comprise or consist of two independent species: Umosilactobacillus fermentum and Lactobacillus delbrueckii, particularly Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, advantageously in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count),
[0077] wherein, preferably, the gelling substance makes up 0.5-20 wt%, more preferably 0.75-10 wt%, even more preferably 1-5 wt% of the gelled composition,
[0078] wherein, preferably, the sweetener makes up 40-80 wt%, more preferably 60-75 wt% of the gelled composition,
[0079] wherein, preferably, the edible acid makes up 0.5-2 wt% of the gelled composition, more preferably ascorbic acid and / or citric acid, and
[0080] wherein, preferably, the gelled composition comprises 15-30 wt% water.
[0081] In addition, the gelled composition can contain optional ingredients, preferably up to 5 wt% based on the total weight of the gelled composition. Optional ingredients are, for example, flavouring, colorant, emulsifier, sanding or coating agent.
[0082] A flavouring agent can be, for example, orange, berry, citrus, strawberry, apricot, peach, mango, etc. flavour, and it can enhance the overall flavour and can make the gummy composition appealing to consumers.
[0083] A colouring agent enhances visual appeal and helps differentiate between different Flavors. An emulsifier ensures that the ingredients are evenly distributed throughout the gummy composition, preventing separation and maintaining a consistent texture. Typical emulsifier is lecithin.2025P00124WO (34829- WO- PCT)
[0084] 11
[0085] A coating agent, such as carnauba wax or beeswax, or a sanding agent, such as sugar powder, can be applied to the surface to prevent sticking and improve the appearance. A wax also provides a glossy finish.
[0086] Furthermore, the gelled composition according to the present invention can also comprise further active ingredients (next to the postbiotic powder). Preferred active ingredients for the embodiment of the present invention may include vitamins, carotenoids, nutritional lipids, minerals, nutraceuticals, amino acids, botanicals (e.g. lemon balm, curcumin), prebiotics, probiotics, fibres or combination thereof that are useful in human nutrition. Such additional active ingredients may be present in amount of up to 10-15 wt%, based on the total weight of the gelled composition.
[0087] Especially preferred embodiments of the first aspect of the invention are gelled composition for oral administration comprising:
[0088] a composition containing dead / inactivated cells from the Lactobacillaceae family comprising or consisting of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, advantageously in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count) with or in the dried fermentation medium from which they are derived and the medium components therein, as component A, a gelling substance comprising gelatine and / or pectin, preferably pectin,
[0089] a sweetener,
[0090] an edible acid,
[0091] - water, and
[0092] optionally one or more of a flavouring, a colorant, an emulsifier or a coating / sanding agent,
[0093] wherein component A comprises 30-90, preferably 50-80 or 60-80 billion cell bodies per gram and is present in 2-8 wt%, preferably 3-7 wt% based on the total weight of the gelled composition, and component A
[0094] is substantially free from lactose, preferably free from lactose, and comprises
[0095] o maltodextrin, preferably maltodextrin of 8-16 DE, more preferably in 65-85 wt% based on the total weight of component A, even more preferably in 70-80 wt% or 75-82 wt%, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously, o cellobiose, preferably in 65-87 wt% based on the total weight of component A, even more preferably 75-85 wt%, and optionally a carbohydrate different from2025P00124WO (34829- WO- PCT)
[0096] 12
[0097] lactose which has been used as energy and / or carbon source in the fermentation previously, or
[0098] o cellobiose and maltodextrin, the maltodextrin being preferably maltodextrin of 8- 20 DE, preferably in 65-85 wt% based on the total weight of component A’, even more preferably 70-80 wt% or 75-82 wt%, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously,
[0099] or
[0100] comprises lactose, preferably
[0101] o in 50-85 wt% based on the total weight of component A, preferably in 65-85 wt%, more preferably in 70-80 wt% or 75-82 wt%, or
[0102] o in 15-23 wt% based on the total weight of component A’ and further comprises ■ maltodextrin, preferably maltodextrin of 8-16 DE, more preferably wherein the lactose and maltodextrin together are present in 50-85 wt% based on the total weight of component A, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%, or
[0103] ■ cellobiose, more preferably wherein the lactose and cellobiose together are present in 50-85 wt% based on the total weight of component A, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%, or ■ maltodextrin and cellobiose, preferably the maltodextrin being maltodextrin of 8-16 DE, more preferably wherein the lactose, maltodextrin and cellobiose together are present in 50-85 wt% based on the total weight of component A, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%,
[0104] wherein the gelling substance comprising gelatine and / or pectin, preferably pectin, is present in 0.75-10 wt%, preferably 1-5 wt%, more preferably 1.25-3 wt% based on the total weight of the gelled composition,
[0105] wherein the sweetener comprises one or more of sucrose, glucose, fructose, maltose, maltooligosaccharide and / or a sugar alcohol, wherein the sugar alcohol is preferably xylitol, maltitol or sorbitol, more preferably the sugar alcohol selected from the group consisting of xylitol and maltitol, and is present in 40-80 wt%, more preferably 60-75 wt%, even more preferably 65-75 wt% based on the total weight of the gelled composition,2025P00124WO (34829- WO- PCT)
[0106] 13
[0107] sweetener is one or more of sucrose, glucose, fructose, maltose, maltooligosaccharide, xylitol, maltitol or sorbitol
[0108] wherein the edible acid, preferably ascorbic acid and / or citric acid, is present in 0.5-2 wt%, preferably 0.7-1.1 wt% based on the total weight of the gelled composition, and
[0109] wherein the gelled composition comprises 15-30 wt%, preferably 20-25 wt% water based on the total weight of the gelled composition.
[0110] The second aspect of the present application relates to a method for producing a gelled composition for oral administration comprising dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, as defined in the first aspect of the invention, the method comprising the steps of:
[0111] a) mixing and heating a gelling agent, a first portion of a sweetener, preferably in powder form, and an edible acid, preferably its nutritionally acceptable salt, in water, b) adding a warm syrup of a second portion of the sweetener to the solution obtained in step a) and heating further,
[0112] c) adding an aqueous solution of a composition, preferably a powder, containing the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein to the solution obtained in step b), optionally with an emulsifier and / or one or more of further active ingredients, and heating further to obtain a liquid gummy mass,
[0113] d) optionally, adding a flavouring and / or a colorant, to the gummy mass obtained in step c) and distribute evenly,
[0114] e) addition of an edible acid,
[0115] f) depositing the warm liquid gummy mass obtained in step e) into moulds and allowing to cool and dry, and optionally
[0116] g) coating the so-obtained gelled composition with glazing and / or sanding agent.
[0117] Preferably, in the method disclosed above the weight ratio of the sweetener to the gelling agent is around 30 to 45 (based on dry matter).
[0118] Also preferably, the weight ratio of the powder of the dead / inactivated cells to the gelling agent is around 1 to 4.5 (based on dry matter).
[0119] Also preferably, the weight ratio of the edible acid to the gelling agent is around 0.4 to 0.55 (based on dry matter).2025P00124WO (34829- WO- PCT)
[0120] 14
[0121] Also preferably, 35-60 % of the total sweetener is used is step a) and the rest in in step b). The sweetener used in step a) and step b) is not necessarily identical and can be a mixture of sweeteners. Further preferably, the sweetener used in step a) is applied as a powder and dry mixed with the powdered form of the gelling agent and the powdered form of the edible acid before preparing their aqueous solution. Such an aqueous solution in step a) is preferably 50-65 wt% in terms of the dissolved solids. Also preferably, the syrup or solution of the second portion of the sweetener used in step b) is rather concentrated, at least 75 wt%, preferably at least 80 wt%.
[0122] In step c), the concentration of the aqueous solution is preferably 40-60 wt%, more preferably around 50 wt%.
[0123] Additionally preferably, the edible acid is added as its nutritionally accepted salt in step a) and as an aqueous solution of the acidic form is step e). Further preferably, the edible acid in step a) is ascorbic acid, more preferably sodium ascorbate, and the edible acid in step e) is citric or malic acid, preferably citric acid.
[0124] Further preferably, a solution or syrup of 76-78 Bx° is obtained is step d).
[0125] The third aspect of the invention relates to a gelled composition for oral administration comprising a composition containing dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, obtained or obtainable by the method comprising the steps:
[0126] i) heating an aqueous solution of comprising a gelling agent, a first portion of a sweetener and an edible acid, preferably a nutritionally acceptable salt of an edible acid, in water at 60-80 °C until the gelling agent is hydrated,
[0127] ii) adding a warm syrup or solution of a second portion of the sweetener to the solution obtained in step i) and brought to boiling until a solution or syrup of 75-80 Bx° is obtained,
[0128] iii) adding a 25-75 wt% aqueous solution of a composition, preferably a powder, containing the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein and optionally an emulsifier and / or one or more of further active ingredients to the solution obtained in step ii),
[0129] iv) continuing boiling the solution obtained in step iii) until a solution or syrup of 75-80 Bx° is obtained,
[0130] v) optionally, adding a flavouring and / or a colorant to the solution obtained in step iv) and distributing evenly,2025P00124WO (34829- WO- PCT)
[0131] 15
[0132] vi) adding an edible acid to set the pH of the solution obtained in step iv) or v) to 2.8-3.8, vii) depositing the warm liquid gummy mass obtained in step vi) into moulds and allowing to cool and dry, and optionally
[0133] viii) coating the so-obtained gelled composition with glazing and / or sanding agent.
[0134] In the third aspect of the invention, the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein is preferably a powder composition comprising said dead / inactivated cells with the dried fermented medium and a drying aid such as lactose, maltodextrin or cellobiose. The preferred embodiments are thoroughly disclosed and defined in the first aspect of the invention.
[0135] In the third aspect of the invention, the gelling agent is preferably gelatine and / or pectin, more preferably pectin. The sweetener, in one group of embodiments, is preferably a usual sugar typically used for gelled confections to make them sweet, such as sucrose, glucose, fructose, maltose, maltooligosaccharides or any mixture thereof. In other group of embodiments, particularly for consumption by diabetics or those who wish to control calorie intake, the sweetener is a low-calorie sugar alcohol, such as xylitol, erythritol, sorbitol, mannitol, isomalt, maltitol or any mixture thereof. In other group of embodiments, the sweetener comprises usual sugar together with low-calorie sugar alcohol. The edible acid is preferably ascorbic acid, citric acid, malic acid, their nutritionally acceptable salt or any mixture thereof.
[0136] Preferably, in the method disclosed above the weight ratio of the sweetener to the gelling agent is around 30 to 45 (based on dry matter).
[0137] Also preferably, the weight ratio of the powder of the dead / inactivated cells to the gelling agent is around 1 to 4.5 (based on dry matter).
[0138] Also preferably, the weight ratio of the edible acid to the gelling agent is around 0.4 to 0.55 (based on dry matter).
[0139] Also preferably, 35-60 % of the total sweetener is used in step i) and the rest in step ii). The sweetener used in step i) and step ii) is not necessarily identical and can be a mixture of sweeteners. Further preferably, the sweetener used in step i) is applied as a powder and dry mixed with the powdered form of the gelling agent and the powdered form of the edible acid before preparing their aqueous solution. Such an aqueous solution in step i) is preferably 50-65 wt% in terms of the dissolved solids. Also preferably, the syrup or solution of the second portion of the sweetener used in step ii) is rather concentrated, at least 75 wt%, preferably at least 80 wt%.2025P00124WO (34829- WO- PCT)
[0140] 16
[0141] In step iii), the concentration of the aqueous solution is preferably 40-60 wt%, more preferably around 50 wt%.
[0142] Additionally preferably, the edible acid is added as its nutritionally accepted salt in step i) and as an aqueous solution of the acidic form is step vi). Further preferably, the edible acid in step i) is ascorbic acid, more preferably sodium ascorbate, and the edible acid in step vi) is citric or malic acid, preferably citric acid.
[0143] Further preferably, a solution or syrup of 76-78 Bx° is obtained is step iv).
[0144] Also preferably, the gelled composition obtained or obtainable by the method disclosed above is the gelled composition as defined in the first aspect of the invention, including the preferred and more preferred embodiments therein.
[0145] A preferred embodiment of the third aspect of the invention relates to a gelled composition for oral administration comprising a composition containing dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, obtained or obtainable by the method comprising the steps:
[0146] i) heating an aqueous solution of comprising a gelling agent, a first portion of a sweetener and an edible acid, preferably a nutritionally acceptable salt of an edible acid, in water at 60-80 °C until the gelling agent is hydrated,
[0147] ii) adding a warm syrup or solution of a second portion of the sweetener to the solution obtained in step i) and brought to boiling until a solution or syrup of 75-80 Bx°, preferably 76-78 Bx° is obtained,
[0148] iii) adding a 25-75 wt%, preferably 40-60 wt%, more preferably around 50 wt% aqueous solution of the composition, preferably the powder composition, containing the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein and optionally an emulsifier and / or one or more of further active ingredients to the solution obtained in step ii),
[0149] iv) continuing boiling the solution obtained in step iii) until a solution or syrup of 75-80 Bx°, preferably 76-78 Bx° is obtained,
[0150] v) optionally, adding a flavouring and / or a colorant to the solution obtained in step iv) and distributing evenly,
[0151] vi) adding an edible acid to set the pH of the solution obtained in step iv) or v) to 2.8-3.8,2025P00124WO (34829- WO- PCT)
[0152] 17
[0153] vii) depositing the warm liquid gummy mass obtained in step vi) into moulds and allowing to cool and dry, and optionally
[0154] viii) coating the so-obtained gelled composition with glazing and / or sanding agent, wherein the gelling agent is pectin, the sweetener is one or more of sucrose, glucose, fructose, maltose, maltooligosaccharide, xylitol, maltitol or sorbitol, the edible acid is one or more of ascorbic acid, citric acid or malic acid, the dead / inactivated cells from the Lactobacillaceae family dead / inactivated cells from the Lactobacillaceae family comprising or consisting of Umosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, advantageously in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count), the composition, preferably the powder composition, containing the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components is characterized by one of the following:
[0155] comprising lactose in 50-85 wt% based on the total weight of the powder, preferably in 65-85 wt%, more preferably in 70-80 wt% or 75-82 wt%,
[0156] comprising lactose in 15-23 wt% based on the total weight of the powder and further comprises maltodextrin, preferably maltodextrin of 8-16 DE, more preferably wherein the lactose and maltodextrin together are present in 50-85 wt% based on the total weight of the powder, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%, comprising lactose in 15-23 wt% based on the total weight of the powder and further comprises cellobiose, more preferably wherein the lactose and cellobiose together are present in 50-85 wt% based on the total weight of the powder, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%,
[0157] comprising lactose in 15-23 wt% based on the total weight of the powder and further comprises maltodextrin and cellobiose, preferably the maltodextrin being maltodextrin of 8-16 DE, more preferably wherein the lactose, maltodextrin and cellobiose together are present in 50-85 wt% based on the total weight of the powder, even more preferably in 65-85 wt%, particularly in 70-80 wt% or 75-82 wt%,
[0158] being substantially free from lactose, preferably free from lactose, and comprising maltodextrin, preferably maltodextrin of 8-16 DE, more preferably in 65-85 wt% based on the total weight of the powder, even more preferably in 70-80 wt% or 75-82 wt%, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously,
[0159] being substantially free from lactose, preferably free from lactose, and comprising cellobiose, preferably in 65-85 wt% based on the total weight of the powder, even more2025P00124WO (34829- WO- PCT)
[0160] 18
[0161] preferably 70-80 wt% or 75-82 wt%, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously, or being substantially free from lactose, preferably free from lactose, and comprising cellobiose and maltodextrin, the maltodextrin preferably being maltodextrin of 8-16 DE, preferably in 65-85 wt% based on the total weight of the powder, even more preferably 70-80 wt% or 75-82 wt%, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously.
[0162] The above disclosed method preferably leads to the gelled composition for oral administration comprising:
[0163] dead / inactivated cells from the Lactobacillaceae family as specified above,
[0164] a gelling substance being pectin,
[0165] a sweetener as specified above,
[0166] an edible acid as specified above,
[0167] - water, and
[0168] optionally one or more of a flavouring, a colorant, an emulsifier, a further active ingredients or a coating / sanding agent,
[0169] wherein the pectin is present in 0.75-10 wt%, preferably 1-5 wt%, more preferably 1.25-3 wt% based on the total weight of the gelled composition,
[0170] wherein the sweetener is present in 40-80 wt%, more preferably 60-75 wt%, even more preferably 65-75 wt% based on the total weight of the gelled composition,
[0171] wherein the edible acid is present in 0.5-2 wt%, preferably 0.7-1.1 wt% based on the total weight of the gelled composition, and
[0172] wherein the gelled composition comprises 15-30 wt%, preferably 20-25 wt% water based on the total weight of the gelled composition.
[0173] The gelled composition according to the first or third aspect of the invention is an advantageous formulation to provide the benefits of a postbiotic powder to customers. One of the advantages is its ease of consumption: the claimed gelled compositions are easy and convenient without the need for water or mixing as opposed to powders which often require preparation. This feature significantly enhances consumer compliance; the enjoyable taste and texture can improve adherence to a supplementation regimen, especially among children and elderly individuals who may struggle with conventional oral dosage forms of postbiotics like swallowing pills or drinking powders. Furthermore, the gelled composition is portable and can be taken on-2025P00124WO (34829- WO- PCT)
[0174] 19
[0175] the-go, especially suitable forthose having a busy lifestyle. The gummy composition according to the invention can easily be integrated into daily routines as a treat, making it less likely for consumers to forget their supplements.
[0176] The gelled composition according to the first or third aspect of the invention can vary in size, typically having a weight of approx. 3-4.5 g. The postbiotic derived from Lactobacillaceae is contained in one gummy so that 1-4 servings represent the recommended daily dose, that is approx, the intake of 20 billion intact cell bodies, to help digestive comfort and health, support normal function of the immune system and / or offer antipathogenic activity e.g. in case of diarrhoea.
[0177] The gelled compositions according to the first and third aspect of the invention are proved to be stable preparations that makes them suitable for commercialization. Under either normal condition (25 °C, 60 % RH) or accelerated stability condition (40 °C, 75 % RH) the gelled compositions did not show significant change in cell count after 1 year or 6 months, respectively. The embodiments of the gelled composition according to the first or the third aspect of the invention that are substantially free from lactose, preferably free from lactose, and contain dead / inactivated cells from the Lactobacillaceae family, preferably those comprising or consisting of Umosilactobacillus fermentum CNCM I-2998 and / or Lactobacillus delbrueckii CNCM 1-4831, advantageously in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count) with or in the dried fermentation medium from which they are derived and the medium components therein, as disclosed above, especially offer the benefits of the presently commercialized lactose containing postbiotic powders for those who cannot or don’t consume lactose due to dietary choices or health-related reasons. Furthermore, the powder composition of the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, which is substantially free from lactose, preferably free from lactose, and used for making the gelled composition according to the first or the third aspect of the invention, contains higher amounts of useful fermentation metabolites at the same or similar cell count compared to the commercial lactose-containing Humiome® Post LB powder. Therefore, increase of these metabolites in the lactose-free postbiotic powder and thereby in the gelled composition according to the first or the third aspect of the invention comprising the lactose-free postbiotic powder is deemed positive and beneficial.
[0178] The fourth aspect of the invention relates to a non-medical use of the gelled composition as defined in the first or the third aspect of the invention, including the preferred and more preferred embodiments, for enhancing performance and perception of well-being in a healthy state of a mammal / individual or in a mammal / individual that is not likely to develop a2025P00124WO (34829- WO- PCT)
[0179] 20
[0180] pathological state. The mammal is preferably human. One embodiment of use for enhancing performance and perception of well-being is dietary supplementation. In this regard, the gelled composition as defined in the first or the third aspect of the invention can be used as a nutraceutical composition.
[0181] EXAMPLES
[0182] Example 1
[0183] Preparation of the lactose-free postbiotic powder
[0184] A culture medium comprising yeast extract , sodium acetate dipotassium phosphate and glucose (30 g / l) was inoculated with Lactobacillus LB {Lm. fermentum and L. delbrueckii in about a 9:1 ratio, deposited at the Collection Nationale de Cultures de Microorganismes (CNCM) with the reference code MA 65 / 4E) and fermented at 37 °C for 16 hours to reach a cell count of 1-1.5 billion / ml. Residual glucose was 13 g / l. The fermentation broth was concentrated under vacuum to cca.1 / 5thof the original volume, to which a filtered biomass from a parallel Lactobacillus LB fermentation was added to set the total solids to be 21 w / v%. The pH of the so obtained suspension was set to 5 with calcium carbonate and subjected to thermal treatment (110 °C, 1 h) to inactivate the cells.
[0185] The concentrated and heat-treated suspension obtained above was dried in a fluid bed dryer using maltodextrin of DE 12 at 50 °C to produce a free flowing creamy yellow powder, wherein 3.5 kg of maltodextrin was used for each kg of the total solids in the suspension. Results: maltodextrin: 74 wt%, glucose: 4.0 wt%, cell count: 70 billion / g.
[0186] Example 2
[0187] General procedure for making the gelled composition
[0188] Pectin APC 185 (dsm-firmenich), sodium ascorbate and powdered sucrose (#1), xylitol (#2) or maltitol (#3) were dry blended and added to warm water (70 °C), and the pectin was let hydrate under stirring (approx. 10-15 min). Preheated glucose syrup (81 wt%, made from corn starch containing glucose, maltose and maltooligosaccharides, for#1) or maltitol / sorbitol syrup (85 wt%, LYCASIN® 85 / 55 (Roquette), for #2 and #3) was added to the pectin solution obtained above and the mixture was cooked until 76-78 Bx° was reached (measured by refractometer or by weighting the gummy mass and calculating the evaporated water). A 50 wt% aqueous solution made from the dried postbiotic powder of heat-deactivated Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831 cells (ratio: 19:1) together with their dried fermentation medium (containing 82 wt% lactose and 62 billion intact cells per gram for#1; containing 80 wt% lactose and 71 billion intact cells per gram for #2; containing 74 wt% maltodextrin, 4 wt% glucose and 70 billion intact cells per gram, lactose-free, for #3) was2025P00124WO (34829- WO- PCT)
[0189] 21
[0190] added to the syrup above and the cooking was continued until 76-78 Bx° was reached. Then apricot flavour (0.1 wt% solution, #1) or “Hot Mix Flavor 523501 A” (a natural flavouring by dsm-firmenich) and peach flavour (both 0.1 wt% solutions, #2) were added, followed by addition of colorant (Redivio® Lycopene, 0.06 wt% solution, #2), and in each case a 50 wt% citric acid solution was added to set the pH to 3-3.5 under continuous stirring to distribute the ingredients evenly. Using a pre-warmed filling funnel, the jelly mass was poured in silicon moulds and allowed to solidify for 24 hours under ambient conditions. The so-obtained gelled compositions were removed from the moulds and coated with glazing agent.
[0191] The table below shows the ingredients used for preparing the gelled compositions according to the protocol disclosed above for 100 g scale:
[0192] #1 #2 #3 sucrose 35.9 g xylitol 26.35 g maltitol 33.0 g pectin A PC 185 2.0 g pectin A PC 185 1.6 g pectin A PC 185 2.0 g sodium ascorbate 0.6 g sodium ascorbate 0.48 g sodium ascorbate 0.6 g water 22 g water 20 g water 30 g glucose syrup 33 g LYCASIN® 85 / 55 45 g LYCASIN® 85 / 55 60 g postbiotic powder 2.9 g postbiotic powder 5.75 g postbiotic powder 7.5 g apricot flavour 0.08 g Hot Mix flavour 0.05 g
[0193] peach flavour 0.0026 g
[0194] Redivio® Lycopene 0.4 g
[0195]
[0196] citric acid 0.3 g citric acid 0.24 g citric acid 0.34 g
[0197] The table below shows the amounts of ingredients in the obtained gelled compositions after cooking in wt%:
[0198] #1 #2 #3
[0199] sucrose 40.9 % xylitol 28.3 % maltitol 27.3 % pectin 2.3 % pectin 1.7 % pectin 1.7 % sodium ascorbate 0.7 % sodium ascorbate 0.5 % sodium ascorbate 0.5 % water 22 % water 22 % water 22 % glucose, maltose and
[0200] 30.5 % maltitol / sorbitol 41 % maltitol / sorbitol 42 % maltooligosaccharides
[0201] postbiotic powder 3.3 % postbiotic powder 6.2 % postbiotic powder 6.2 % apricot flavour traces Hot Mix flavour traces
[0202] peach flavour traces
[0203] Redivio® Lycopene traces
[0204]
[0205] citric acid 0.3 % citric acid 0.3 % citric acid 0.3 %2025P00124WO (34829- WO- PCT)
[0206] 22
[0207] Gelled composition #2 represents a low-calorie variant of gelled composition #1, especially suitable for diabetics. Gelled composition #3 represent a low-calorie and lactose-free variant, especially suitable for diabetics and / or vegans or people suffering from lactose intolerance. Example 3
[0208] Metabolites produced during fermentation and present in the powders were measured in three batches of a lactose-free postbiotic composition and compared to those in three batches of reference Humiome® Post LB containing lactose.
[0209] lactose-free postbiotic fluid bed dried Humiome® Post LB powders powders lactose (wt%) - 68-70 glucose (wt%) 3.4-4.4 - maltodextrin (wt%) 77-78 - lactic acid bacteria (billion
[0210] 70-79 64-75
[0211]
[0212] cells / g)
[0213] Lactic acid was analysed by liquid chromatography mass spectrometry (LC-MS) using a modified version of the methods disclosed in the prior art (Shafaei et al. Anal. Bioanal. Chem.
[0214] 413, 6333 (2021); Liebisch et al. Biomolecules 9, 121 (2019); Han et al. Anal. Chim. Acta 854, 86 (2015)) using a Thermo Scientific Accela UHPLC system coupled to a Q Exactive Orbitrap mass spectrometer. Pure lactic acid was used as calibration control and internal standard. Postbiotic samples were extracted in a 50% methanol, the supernatant containing lactic acid: was derivatized with13Ce-labeled 3-nitrophenylhydrazine (3NPH) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) in a solvent mixture of water and acetonitrile containing pyrimidine. Derivatized samples and calibration standard were diluted in water and analysed by LC-MS on a Thermo Scientific Accela UHPLC system using a C18 column coupled to a Q Exactive Orbitrap mass spectrometer (MS) with atmospheric pressure chemical ionization (APCI).
[0215] GABA (y-aminobutyric acid) was analysed by LC-MS without prior derivatization using adaptation of known methods (Wu et al. Food Funct. 10, 6484 (2019); Jia et al. Molecules 25, 1862 (2020); Hefni et al. Anal. Bioanal. Chem. 413, 5349 (2021); Lamy et al. Taianta 224, 121881 (2021)). Postbiotic samples were extracted as described above and the internal standards in acetonitrile were added to the supernatants. Analysis was performed with a Thermo Vanquish UHPLC system equipped with a Waters Aquity UPLC BEH HILIC column with a gradient elution of ammonium formate and formic acid in water (eluent A) and acetonitrile (eluent B). Thereafter, fractions were analysed by positive electrospray ionization mass spectrometry on a Thermo Stellar mass spectrometer.2025P00124WG (34829- WO- PCT)
[0216] 23
[0217] The comparative analysis showed that the lactose-free postbiotic powders contained higher concentration of useful fermentation metabolites at the same or similar cell count compared to the commercial lactose-containing Humiome® Post LB. Notably, the following average increases were measured: lactic acid 28 %; GABA 298 %. Lactic acid is a beneficial compound produced by certain gut bacteria, especially Lactobacillus species, during the fermentation of carbohydrates. Higher levels of lactic acid in the gut help maintain a healthy pH balance, inhibit the growth of harmful microbes, and support overall gut barrier integrity and immune function. GABA is a key inhibitory neurotransmitter that helps calm brain activity and is also produced in the gut, where it influences the gut-brain axis. Higher levels of GABA are generally associated with reduced anxiety and depression symptoms, and certain gut microbes that boost GABA production may support mental well-being by positively affecting mood-regulating neural pathways. Therefore, increase of these metabolites in the lactose-free postbiotic powder and thereby in the gelled composition according to the present invention comprising the lactose-free postbiotic powder is deemed positive and beneficial.
Claims
2025P00124WO (34829- WO- PCT)24CLAIMS1. A gelled composition for oral administration comprising a composition containing dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein, preferably in 2-8 wt% based on the total weight of the gelled composition.
2. The gelled composition according to claim 1 , wherein the inactivated Lactobacillaceae cells belong to the genus Limosilactobacillus and / or to the genus Lactobacillus, preferably a species in the Limosilactobacillus genus is Limosilactobacillus fermentum and / or a species in the Lactobacillus genus is Lactobacillus delbrueckii.
3. The gelled composition according to claim 1 or 2, wherein the Lactobacillaceae cells comprise or consist of Limosilactobacillus fermentum and Lactobacillus delbrueckii, preferably the Limosilactobacillus fermentum being Limosilactobacillus fermentum CNCM I- 2998 and the Lactobacillus delbrueckii being Lactobacillus delbrueckii CNCM 1-4831.
4. The gelled composition according to claim 3, wherein the Limosilactobacillus fermentum and Lactobacillus delbrueckii are present in about a 9:1-50:1, even more preferably about 19:1 ratio by intact cell count.
5. The gelled composition according to any of the claims 1 to 4, further comprising a gelling substance, a sweetener, an edible acid and water.
6. The gelled composition according to claim 5, whereinthe gelling substance is in 0.5-20 wt%, more preferably in 0.75-10 wt%, even more preferably in 1-5 wt%,the sweetener is in 40-80 wt%, more preferably in 60-75 wt%,the edible acid makes in 0.5-2 wt%, andthe water is in 15-30 wt%based on the total weight of the gelled composition.
7. The gelled composition according to claim 5 or 6, wherein the gelling substance is pectin and the edible acid is ascorbic acid and / or citric acid.
8. The gelled composition according to any of the preceding claims, comprisinga composition containing dead / inactivated cells from the Lactobacillaceae family comprising or consisting of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, advantageously in about a 9:1-50:1, more2025P00124WO (34829- WO- PCT)25preferably about 19:1 ratio (by intact cell count) with or in the dried fermentation medium from which they are derived and the medium components therein, as component A’,a gelling substance comprising gelatine and / or pectin, preferably pectin,a sweetener,an edible acid,- water, andoptionally one or more of a flavouring, a colorant, an emulsifier or a coating / sanding agent,wherein component A comprises 30-90 billion cell bodies per gram and is present in 2-8 wt% based on the total weight of the gelled composition, and component Acomprises lactose, preferablyo in 50-85 wt% based on the total weight of component A, oro in 15-23 wt% based on the total weight of component A’ and further comprises ■ maltodextrin, preferably maltodextrin of 8-16 DE, more preferably wherein the lactose and maltodextrin together are present in 50-85 wt% based on the total weight of component A, or■ cellobiose, preferably wherein the lactose and cellobiose together are present in 50-85 wt% based on the total weight of component A, or ■ maltodextrin and cellobiose, preferably the maltodextrin being maltodextrin of 8-16 DE, more preferably wherein the lactose, maltodextrin and cellobiose together are present in 50-85 wt% based on the total weight of component A.
9. The gelled composition according any of the claims 1 to 7, which is substantially free from lactose, preferably free from lactose.
10. The gelled composition according to claim 9, comprisinga composition containing dead / inactivated cells from the Lactobacillaceae family comprising or consisting of Limosilactobacillus fermentum CNCM I-2998 and Lactobacillus delbrueckii CNCM 1-4831, advantageously in about a 9:1-50:1, more preferably about 19:1 ratio (by intact cell count) with or in the dried fermentation medium from which they are derived and the medium components therein, as component A,2025P00124WO (34829- WO- PCT)26a gelling substance comprising gelatine and / or pectin, preferably pectin,a sweetener,an edible acid,- water, andoptionally one or more of a flavouring, a colorant, an emulsifier or a coating / sanding agent,wherein component A’ comprises 30-90 billion cell bodies per gram and is present in 2-8 wt% based on the total weight of the gelled composition, and component A comprises o maltodextrin, preferably maltodextrin of 8-16 DE, more preferably in 65-85 wt% based on the total weight of component A, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously,o cellobiose, preferably in 65-87 wt% based on the total weight of component A, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously, oro cellobiose and maltodextrin, the maltodextrin being preferably maltodextrin of 8- 20 DE, preferably in 65-85 wt% based on the total weight of component A, and optionally a carbohydrate different from lactose which has been used as energy and / or carbon source in the fermentation previously.
11. A method for producing a gelled composition defined in any of the preceding claims, the method comprising the steps of:a) mixing and heating a gelling agent, a first portion of a sweetener, preferably in powder form, and an edible acid, preferably its nutritionally acceptable salt, in water, b) adding a warm syrup of a second portion of the sweetener to the solution obtained in step a) and heating further,c) adding an aqueous solution of a composition, preferably a powder composition, containing the dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein to the solution obtained in step b), optionally with an emulsifier and / or one or more of further active ingredients, and heating further to obtain a liquid gummy mass,2025P00124WO (34829- WO- PCT)27d) optionally, adding a flavouring and / or a colorant, to the gummy mass obtained in step c) and distribute evenly,e) addition of an edible acid,f) depositing the warm liquid gummy mass obtained in step e) into moulds and allowing to cool and dry, and optionallyg) coating the so-obtained gelled composition with glazing and / or sanding agent.
12. A gelled composition for oral administration obtained or obtainable by the method comprising the steps:i) heating an aqueous solution of comprising a gelling agent, a first portion of a sweetener and an edible acid, preferably a nutritionally acceptable salt of an edible acid, in water at 60-80 °C until the gelling agent is hydrated,ii) adding a warm syrup or solution of a second portion of the sweetener to the solution obtained in step i) and brought to boiling until a solution or syrup of 75-80 Bx° is obtained,iii) adding a 25-75 wt% aqueous solution of a composition, preferably a powder composition, comprising dead / inactivated cells from the Lactobacillaceae family with or in the dried fermentation medium from which they are derived and the medium components therein and optionally adding an emulsifier and / or one or more of further active ingredients to the solution obtained in step ii),iv) continuing boiling the solution obtained in step iii) until a solution or syrup of 75-80 Bx° is obtained,v) optionally, adding a flavouring and / or a colorant to the solution obtained in step iv) and distributing evenly,vi) adding an edible acid to set the pH of the solution obtained in step iv) or v) to 2.8- 3.8,vii) depositing the warm liquid gummy mass obtained in step vi) into moulds and allowing to cool and dry, and optionallyviii) coating the so-obtained gelled composition with glazing and / or sanding agent, preferably the gelled composition obtained or obtainable by the method is as defined in any of the claim 1 to 10.
13. A non-medical use of the gelled composition as defined in any of the claims 1 to 10 and 12 for enhancing performance and perception of well-being in a healthy mammal / individual.
